Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-21,479
Closed -$2.21M 86
2023
Q3
$2.21M Buy
21,479
+186
+0.9% +$20K 1.68% 21
2023
Q2
$2.46M Buy
21,293
+64
+0.3% +$7.27K 0.52% 55
2023
Q1
$2.26M Buy
21,229
+232
+1% +$25K 0.43% 70
2022
Q4
$2.32M Sell
20,997
-1,016
-5% -$104K 0.47% 69
2022
Q3
$1.9M Buy
22,013
+1,679
+8% +$150K 0.4% 78
2022
Q2
$1.85M Sell
20,334
-2,376
-10% -$211K 0.39% 73
2022
Q1
$1.86M Buy
22,710
+57
+0.3% +$4.49K 0.34% 80
2021
Q4
$1.74M Buy
+22,653
New +$1.8M 0.34% 83

Other funds holding MRK

TCWP's MRK Position: Q4 2023 in Review

TCWP sold out of Merck (MRK) in Q4 2023, closing a stake of 21,479 shares — an estimated $2.21M sold.

TCWP first reported a position in MRK in Q4 2021 and held it in 8 quarters. The position peaked at $2.46M in Q2 2023. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • TCWP reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • TCWP sold 21,479 Merck shares in Q4 2023, an estimated $2.21M.
  • TCWP first reported a position in Merck in Q4 2021 and held it in 8 quarters.
  • TCWP's Merck position peaked at $2.46M in Q2 2023.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on TCWP's 13F filing for Q4 2023, filed 14 Feb 2024.